Add BrightSurf on Google Email

Science News for August 14, 2000


Ozone threatens Long Island plants

High levels of ground-level ozone have been found to severely impact the growth of ozone-sensitive crops on Long Island, including spinach, grapes, pumpkins, watermelons, and tomatoes. This research highlights the urgent need for attention to be paid to ambient ozone levels in agricultural areas.

Proceedings of the National Academy of Science: animal study points to new method for halting life-threatening blood pressure decline during septis

Researchers have identified a new treatment approach that could reverse the dramatic blood pressure drop associated with septic shock by removing excess superoxide free radicals. The treatment, a MetaPhore SOD mimetic, restored norepinephrine's ability to constrict blood vessels and reversed hypotension in rat models of septic shock.

SourceKupper Parker Communications·JournalProceedings of the National Academy of Sciences·DateAug 14, 2000

Hearing loss a threat to children who survive 'stiff lung' condition at birth

Researchers warn that children born with persistent pulmonary hypertension (PPHN) may be at risk for progressive hearing loss, even if standard auditory testing proves normal in the first weeks of life. Periodic hearing tests every six months until age 3 are recommended to avoid delayed diagnosis and its associated costs.

SourceUniversity of North Carolina Health Care·JournalArchives of Otolaryngology·DateAug 14, 2000

Irvine researcher receives national award

Chemist David L. Van Vranken receives Arthur C. Cope Scholar Award for his studies of protein reactivity patterns, which have led to the development of new drugs targeting cancer and other diseases. His research has also shed light on the effects of aging and environmental factors on proteins in the body.

Harvard researcher receives national award

David A. Evans, an organic chemist at Harvard University, will receive the 2000 Arthur C. Cope Award for his work on developing fundamental chemistry to assemble building blocks and control molecule three-dimensionality. He hopes to improve and modify vancomycin biosynthesis to build more potent or side-effect-free analogs.